1 Min Read
May 1 (Reuters) - Medmira Inc:
* Medmira-Received ce mark on its Syphilis/HIV rapid test, multiplo tp/hiv; approval allows to market and distribute multiplex rapid test throughout EU Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.